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Reply to Luck
We appreciate the interest expressed by Luck 1 in our paper 2 comparing the efficacy and safety of a mydriatic cocktail regimen delivered with a wick with that of conventional application of eye drops in the preoperative mydriasis before cataract surgery. The authors have reported their own results on a similar study that was very well designed and statistically sound. 3 We regret not citing this study in our references. However, contrary to our results, they found no significant difference between the mydriasis obtained with the depot system (wick soaked in a mydriatic cocktail) and the conventional drop application. This disagreement could possibly be attributed to a few fundamental differences between the two studies.
First, we have included diabetics and pseudoexfoliation (PXF) patients in our study and have equally randomized them into the two arms. These two conditions, which are known to be predisposing factors for poor mydriasis, constituted 15% of our study population. However, Dubois et al 3 have excluded patients with these predispositions. We believe that including these conditions makes our study much more applicable to a wider group of patients. Performing a similar study with diabetics and PXF patients alone would reveal whether the cocktail preparation is indeed effective or not.
Second, the exact duration for which the wick was placed in the conjunctival cul-de-sac is not mentioned clearly in the study by Dubois et al. We believe that this is a significant issue for the standardization of such a study and the lack of it may bias the results if some patients receive the wick for longer duration than others.
Another difference is that Dubois et al have excluded eyes with dark-coloured irises. Our study has been conducted in an Indian population, wherein all patients have dark irises. There is a clinically significant difference (41 mm) in the mean pupillary diameters between the two studies in both groups, ie, the mydriatic cocktail group (depot group) and the conventional drops group (Table 1) . Most of our patients (470%) were in the moderate mydriasis group (5.1-8 mm). This suggests that eyes with dark-coloured irises respond differently from lighter-coloured ones. Hence, the two patient groups may not be directly comparable to draw conclusions.
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Case report
A healthy 47-year-old Malay man presented with 2 days of bilateral red eyes associated with pain and blurring of vision. This occurred a week after taking once-daily isoniazid 300 mg as anti-tuberculosis (TB) prophylaxis, prescribed due to a positive tuberculin skin test (TST, 15 mm) after his wife was diagnosed with active pulmonary TB. He was asymptomatic. Chest X-ray, HIV screen, and TB interferon-g release assay (IGRA) (TB T-spot; Oxford Immunotec, Oxford, UK) were negative. Presenting Snellen acuities were 6/12 OD and 6/9 OS. He had bilateral diffuse conjunctival congestion and deep anterior chambers with activity of 2 þ cells. Fundus examination revealed bilateral, shallow, 3601, clear serous choroidal effusions, corroborated on ultrasound B scan imaging (Figure 1a) . No other focal choroidal lesions were observed.
In view of his lack of symptoms and negative IGRA, isoniazid was stopped in consultation with his physician. Complete resolution of anterior uveitis and choroidal effusions was noted 3 days later (Figure 1b) , with no further recurrences.
Discussion
Tuberculosis is a resurgent global disease. WHO's 2009 TB update estimates 33% of the world population is infected, 1.4 million of which have HIV.
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Isoniazid is widely used as prophylaxis or treatment against sensitive strains. Common adverse systemic reactions are hepatotoxicity and peripheral neuropathy. Established ocular side effects include toxic optic neuropathy, retrobulbar neuritis, and optic atrophy. Hypersensitivity reactions have rarely been reported and 
